SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
曹博
Lv4
1
570 积分
2021-09-15 加入
最近求助
最近应助
互助留言
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial
4天前
已完结
Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity
18天前
已完结
Challenges and opportunities in oncology drug development and clinical research in China
21天前
已完结
Pan-cancer single-cell landscape of tumor-infiltrating T cells
1个月前
已完结
Homologous recombination deficiency in cell line libraries does not correlate with in vitro sensitivity to platinum agents or PARP inhibitors
4个月前
已完结
Abemaciclib is effective in palbociclib-resistant hormone receptor-positive metastatic breast cancers
7个月前
已完结
Abemaciclib is effective in palbociclib-resistant hormone receptor-positive metastatic breast cancers
7个月前
已完结
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
9个月前
已完结
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
10个月前
已完结
Antibody–drug conjugates come of age in oncology
10个月前
已完结
没有进行任何应助
文献错误
1年前
下载不了
1年前
感谢
1年前
感谢
1年前
感谢
1年前
thx
1年前
找到了【积分已退回】
2年前
缺少数据表页
2年前
速度真快,感谢
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论